Extremely high follicle-stimulating hormone with normal ovarian function

Clinical Biochemistry · Published 2026-07-07 · DOI 10.1016/j.clinbiochem.2026.111167

Authors (4)

Yu Chen, Jana Bubar, Chelsey Flemming, Ihssan Bouhtiauy

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Chen, Y., Bubar, J., Flemming, C., et al. (2026). Extremely high follicle-stimulating hormone with normal ovarian function. Clinical Biochemistry. https://doi.org/10.1016/j.clinbiochem.2026.111167

Related articles

• The CDKN2A/B rs10811661 polymorphism is associated with metabolic syndrome, insulin resistance, and lipid levels in individuals with obesity and impaired fasting glucose · Clinical Biochemistry · 2026 · Same journal
• Resolving method-dependent M-protein detection: a case of oligoclonality revealed through complementary immunotyping techniques · Clinical Biochemistry · 2026 · Same journal
• Cryoglobulinemia and Cryofibrinogenemia: Ten years of experience and diagnostic perspectives from a large laboratory-based cohort · Clinical Biochemistry · 2026 · Same journal
• Inter-laboratory variability in vancomycin measurement in an external quality assessment scheme 2016–2025 · Clinical Biochemistry · 2026 · Same journal
• Modest sensitivity of 24 h urine free cortisol LC-MS/MS to detect Cushing's disease · Clinical Biochemistry · 2026 · Same journal
• Elevated IL-27 and altered anti-inflammatory cytokine levels in SLE patients with end-stage renal disease · Clinical Biochemistry · 2026 · Same journal
• Evaluating prognostic performance for acute delta changes of high-sensitivity cardiac troponin T in emergency department patients · Clinical Biochemistry · 2026 · Same journal
• Establishment of PCOS-specific prolactin reference intervals to optimize laboratory demand management for macroprolactin screening · Clinical Biochemistry · 2026 · Same journal
• From analytical metrics to clinical impact: Rethinking sigma metrics in the era of EFLM-based specifications · Clinical Biochemistry · 2026 · Same journal
• Integrated genomic and biochemical diagnosis of a novel homozygous start-loss variant in AKR1D1 associated with neonatal cholestasis · Clinical Biochemistry · 2026 · Same journal